Taiwan News

Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile

MRI disease activity significantly reduced with remibrutinib vs. teriflunomide in two trials, including reductions in T2 lesion activity by 65% and 70%, and Gd+ T1 lesions by 66% across both trials¹ ...

Billet Badges Joins NFI Empire’s Project REBORN, Crafting Custom Badging for the One-of-One Charity Build Benefiting The Brett Boyer Foundation

Billet Badges Helps Define the Legacy of Project REBORN. NORTH EAST, PA / ACCESS Newswire / October 19, 2026 / NFI Empire, a ...
Arizona Daily Star

Lean Six Sigma framework for developing doctoral research problem statements outlined in University of Phoenix white paper

Author-developed evidence chain adapts Lean Six Sigma Define and Measure logic to help practitioner researchers build ...

Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.
Taiwan News

Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α ...

SEATTLE, Sept. 14, 2026 (GLOBE NEWSWIRE)-- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN ...
The Globe and Mail

Innodata Releases the First Stage of Its AI Cyber Training Suite to Enable AI Coding Agents to Write - and Repair - Secure Code

Twelve datasets and evaluation systems, built by hand from thousands of real-world security flaws, give model builders and enterprises a proven way to keep AI-generated code from introducing ...